WO2008136394A1 - Method for production of lactam compound, and intermediate for the production method - Google Patents
Method for production of lactam compound, and intermediate for the production method Download PDFInfo
- Publication number
- WO2008136394A1 WO2008136394A1 PCT/JP2008/058038 JP2008058038W WO2008136394A1 WO 2008136394 A1 WO2008136394 A1 WO 2008136394A1 JP 2008058038 W JP2008058038 W JP 2008058038W WO 2008136394 A1 WO2008136394 A1 WO 2008136394A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- production
- lactam compound
- producing
- therapeutic agent
- production method
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Disclosed are: a novel method for producing a lactam compound; and an intermediate for use in the production method. Specifically disclosed are: a simple method for producing a lactam compound that can be used as a therapeutic agent for diabetes or as an intermediate for the production of the therapeutic agent, which can be conducted under mild and safe conditions; and an intermediate which is useful for the production method.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPPCT/JP2007/059545 | 2007-04-27 | ||
PCT/JP2007/059545 WO2008139576A1 (en) | 2007-04-27 | 2007-04-27 | Method for producing lactam compound and production intermediate thereof |
PCT/JP2007/059540 WO2008139574A1 (en) | 2007-04-27 | 2007-04-27 | Crystalline form of lactam compound and process for producing the same |
JPPCT/JP2007/059540 | 2007-04-27 | ||
JPPCT/JP2007/059544 | 2007-04-27 | ||
PCT/JP2007/059544 WO2008139575A1 (en) | 2007-04-27 | 2007-04-27 | Preparation for oral administration |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008136394A1 true WO2008136394A1 (en) | 2008-11-13 |
Family
ID=39943501
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/058037 WO2008136393A1 (en) | 2007-04-27 | 2008-04-25 | Crystal of lactam compound, and method for production thereof |
PCT/JP2008/058036 WO2008136392A1 (en) | 2007-04-27 | 2008-04-25 | Preparation for oral administration |
PCT/JP2008/058038 WO2008136394A1 (en) | 2007-04-27 | 2008-04-25 | Method for production of lactam compound, and intermediate for the production method |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/058037 WO2008136393A1 (en) | 2007-04-27 | 2008-04-25 | Crystal of lactam compound, and method for production thereof |
PCT/JP2008/058036 WO2008136392A1 (en) | 2007-04-27 | 2008-04-25 | Preparation for oral administration |
Country Status (1)
Country | Link |
---|---|
WO (3) | WO2008136393A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011002075A1 (en) * | 2009-07-02 | 2011-01-06 | 味の素株式会社 | Method for producing lactam compound and production intermediate thereof |
WO2011002076A1 (en) * | 2009-07-02 | 2011-01-06 | 味の素株式会社 | Method for producing lactam compound and production intermediate thereof |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110009347A1 (en) | 2009-07-08 | 2011-01-13 | Yin Liang | Combination therapy for the treatment of diabetes |
WO2011107494A1 (en) | 2010-03-03 | 2011-09-09 | Sanofi | Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof |
MY187718A (en) * | 2010-05-11 | 2021-10-14 | Janssen Pharmaceutica Nv | Pharmaceutical formulations |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
KR20170095850A (en) * | 2014-12-22 | 2017-08-23 | 이에이 파마 가부시키가이샤 | Drug for treating disorders of corneal epithelium |
JP6498158B2 (en) * | 2016-07-11 | 2019-04-10 | ニプロ株式会社 | Orally disintegrating tablets |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002044180A1 (en) * | 2000-12-01 | 2002-06-06 | Ajinomoto Co.,Inc. | Lactam compounds and medicinal use thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL136460A0 (en) * | 1997-12-22 | 2001-06-14 | Schering Corp | Molecular dispersion composition with enhanced bioavailability |
JP4327424B2 (en) * | 2000-05-15 | 2009-09-09 | 武田薬品工業株式会社 | Crystal production method |
ITMI20011727A1 (en) * | 2001-08-06 | 2003-02-06 | Recordati Ind Chimica E Farma | LERCANIDIPINE HYDROCHLORIDE SOLVATES AND NEW CRYSTALLINE FORMS OF LERCANIDIPINE HYDROCHLORIDE OBTAINED FROM THEM |
CN101822834A (en) * | 2003-02-07 | 2010-09-08 | 味之素株式会社 | Medicine for treating diabetes |
WO2005013964A1 (en) * | 2003-08-08 | 2005-02-17 | Ajinomoto Co., Inc. | Pharmaceutical preparation containing nateglinide |
EP1683798B1 (en) * | 2003-10-31 | 2016-04-20 | Ajinomoto Co., Inc. | Fused polycyclic compounds having heterocycle and medicinal use thereof |
TW200616634A (en) * | 2004-10-01 | 2006-06-01 | Bristol Myers Squibb Co | Crystalline forms and process for preparing spiro-hydantoin compounds |
CN101166742B (en) * | 2005-04-28 | 2011-07-13 | 味之素株式会社 | Novel lactam compound |
US20090208584A1 (en) * | 2005-06-09 | 2009-08-20 | Tomohiro Yoshinari | Solid preparation |
-
2008
- 2008-04-25 WO PCT/JP2008/058037 patent/WO2008136393A1/en active Application Filing
- 2008-04-25 WO PCT/JP2008/058036 patent/WO2008136392A1/en active Application Filing
- 2008-04-25 WO PCT/JP2008/058038 patent/WO2008136394A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002044180A1 (en) * | 2000-12-01 | 2002-06-06 | Ajinomoto Co.,Inc. | Lactam compounds and medicinal use thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011002075A1 (en) * | 2009-07-02 | 2011-01-06 | 味の素株式会社 | Method for producing lactam compound and production intermediate thereof |
WO2011002076A1 (en) * | 2009-07-02 | 2011-01-06 | 味の素株式会社 | Method for producing lactam compound and production intermediate thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2008136393A1 (en) | 2008-11-13 |
WO2008136392A1 (en) | 2008-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008136394A1 (en) | Method for production of lactam compound, and intermediate for the production method | |
WO2008046581A3 (en) | Substituted tetrahydropyrrolopyrazine compounds and use thereof in medicaments | |
WO2007093627A3 (en) | Biocidal composition | |
WO2007015017A3 (en) | Novel polyquinoline derivatives and the therapeutic use thereof | |
WO2009092752A3 (en) | Polyolefins having isotactic structural elements, method for producing the same and use thereof | |
EP2133077A4 (en) | Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase iv | |
WO2008104306A3 (en) | Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof | |
EP2022806A4 (en) | Process for production of cross copolymers, cross copolymers obtained by the process, and use thereof | |
EP2130909A4 (en) | Method for production of tooth, and tooth produced by the method | |
WO2010078900A3 (en) | Novel aliphatically substituted pyrazolopyridines, and the use thereof | |
ZA201001015B (en) | (Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament | |
WO2008121616A3 (en) | Antibodies with decreased deamidation profiles | |
IL204556A0 (en) | (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament | |
WO2008017962A8 (en) | Microcapsules with improved shells | |
HK1100409A1 (en) | Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments | |
IL213112A (en) | Nalmefene hydrochloride dihydrate | |
EP1908749A4 (en) | Process for production of isocyanate, isocyanate produced by the process, and use of the isocyanate | |
WO2006018184A3 (en) | Spirocyclic cyclohexane derivatives | |
WO2011073279A3 (en) | Cosmetic treatment method involving a compound capable of condensing in situ | |
WO2008035066A3 (en) | Processes for the preparation of ciclesonide and its crystal form | |
EP2019133A4 (en) | MICROORGANISM CAPABLE OF PRODUCING gamma-L-PGA, METHOD FOR PRODUCTION OF gamma-L-PGA USING THE MICROORGANISM, CROSSLINKED PRODUCT, AND AGENT FOR EXTERNAL APPLICATION TO THE SKIN | |
WO2009074247A8 (en) | Novel 2-aryl-thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament | |
WO2008011433A3 (en) | Styrenated terpene resin as well as methods of making and using the same | |
MY146671A (en) | Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents | |
WO2011009533A3 (en) | 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl derivatives, methods for the production thereof and use thereof for treating diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08752112 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08752112 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |